As of November 2024, GeneFerm Biotechnology has a market cap of $60.73M. This makes GeneFerm Biotechnology the world's 24097th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $75.83M | -21.48% |
2023 | $96.58M | 11.36% |
2022 | $86.72M | 50.85% |
2021 | $57.49M | 52.41% |
2020 | $37.72M | -4.90% |
2019 | $39.67M | -27.14% |
2018 | $54.45M | -23.36% |
2017 | $71.04M | -33.98% |
2016 | $107.59M | - |